Browse drugs

…ase family 1A member 1 (ST1A1, gene name SULT1A1) in modulating 5-ASA therapeutic efficacy.Methods Baseline serum from 36 UC patients…

…ained robust PMN-MDSC infiltration (IDDF2026-ABS-0304 Figure 6. INAM promotes liver regeneration without inhibiting SIRT2).Conclusio…

…and upper gastrointestinal cancers were similar between groups. Orlistat was associated with higher risks of kidney stones (5.9% vs 4.5%…

…37% (p<0.001). ETI accounted for 160 cases (64.5%), followed by ivacaftor 57 (23.0%), lumacaftor/ivacaftor 23 (9.3%), and tezacaftor/ivac…

…olonoscopy, with comparable efficacy in BBPS scores. Crucially, Elobixibat, as an adjunct to PEG, is a viable alternative to the current s…

…d 32.1% of patients required restarting or uptitrating of their budesonide treatment due to a return of symptoms. In those requiring furth…

…and upper gastrointestinal cancers were similar between groups. Orlistat was associated with a higher risk of kidney stones (5.9% vs 4.5…

… SC maintenance (100 mg q8w or 200 mg q4w). GRAVITI assessed SC GUS induction (400 mg at W0, W4, and W8) and the same GUS maintenan…

…Introduction Guselkumab (GUS) is a dual-acting IL-23p19 subunit inhibitor that potently…

…l surgery.Advanced therapies used for treatment of OFG included adalimumab (n=56), infliximab (n=52), ustekinumab (n=23), risankizumab (n=…

…excluded. The drugs recorded for this project were Fentanyl and Midazolam. For each drug the volume vial used, dose given, and dose disca…

… said they would be happy to undergo a further colonoscopy with penthrox.All endoscopists strongly agreed that they would be as confiden…